Purchase Order 75N91019P00619

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,130.80 on June 11, 2020, with ultimate completion on June 14, 2021. The order covers a maintenance agreement on a firm fixed price basis. Work is performed in San Diego, California. No set-aside was used.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $4,066.13 on December 4, 2017, with a completion date of January 31, 2018. The order covers a maintenance agreement for Illumina sequencing equipment. Work is performed in San Diego, California. The purchase order carries firm fixed price terms and no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $16,085.00 on April 30, 2019, with a completion date of April 30, 2020. The order covers a maintenance agreement for sequencing equipment, performed in San Diego, California. No set-aside applied to this acquisition.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,130.80, with an award date of June 15, 2020 and ultimate completion date of June 20, 2021. Work is performed in San Diego, California. The order is for service agreement items on a firm fixed price basis with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc., valued at $24,738.00, on July 25, 2017, for software and hardware services, with an ultimate completion date of July 24, 2018. Work is performed in San Diego, California. The order is priced on a firm fixed price basis with no set-aside used.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for emergency service call support on July 16, 2013, with a ceiling value of $1,078.06 and ultimate completion date of July 31, 2013. No set-aside applied. Work is performed in San Diego, California. The order is firm fixed price.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $20,198.50 in scientific equipment, effective February 9, 2021, with completion targeted March 31, 2021. Performance occurs in San Diego, California. The order is firm fixed-price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $16,085.00 on May 17, 2019, with ultimate completion on June 14, 2020. Performance occurs in Bethesda, Maryland. The order is a firm fixed price service agreement with no set-aside applied.</p>

<p>The National Cancer Institute issued a purchase order to Illumina, Inc. for $17,675.00 on July 31, 2019, with ultimate completion on July 31, 2020. The order covers a maintenance agreement for DNA and RNA sequencing equipment, with work performed in San Diego, California. Pricing is firm fixed price with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. for $24,158.08 on October 19, 2017, with an ultimate completion date of November 19, 2018. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Specific requirements are not detailed in the source material.</p>